Patents by Inventor Shlomo Wientroub

Shlomo Wientroub has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Osteoblast and fibroblast antigen and antibodies recognizing it
    Patent number: 6074833
    Abstract: Monoclonal antibodies (MAb) are provided which have binding specificity to an antigen expressed on osteogenic and fibroblastic cells (OFA) and are capable of binding to osteogenic and fibroblastic cells at a substantially higher extent as compared to their binding to skin fibroblasts and stromal adipocytes. Also provided is a novel osteogenic and fibroblastic antigen (OFA) which is expressed on osteogenic and fibroblastic cells at a higher level than its expression in skin fibroblasts and stromal adipocytes having a molecular weight of about 80 kD as determined by western blotting or immunoprecipitation. The OFA and anti-OFA-MAbs are useful in the diagnosis and treatment of various hone related conditions.
    Type: Grant
    Filed: September 30, 1996
    Date of Patent: June 13, 2000
    Assignee: Ramot University Authority
    Inventors: Shlomo Wientroub, Dafna Benayahu
  • Method for regulating bone forming cells
    Patent number: 5688531
    Abstract: Regulation factors and a method for modulating bone forming cells including the steps of collecting regulation factors from bone stromal cells including marrow adipocytes and treating the bone forming cells with the regulation factors derived from stromal cells to modify the bone forming cells.
    Type: Grant
    Filed: December 23, 1994
    Date of Patent: November 18, 1997
    Assignee: Ramot University Authority for Applied Research and Industrial Development, Ltd.
    Inventors: Dafna Benayahu, Shlomo Wientroub